by Khatami, S.M. et al.
Nephrology Research Center, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Iran
Nephrology Research Center, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Iran
We conclude that in patients with mild-to-moderate renal failure, it seems that gadolinium is associated with no or very low risk for NSF.
Ren. Fail. 2012; 2:176-80
